<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A75EF746-05EF-4C54-9701-C4485DDEEE6B"><gtr:id>A75EF746-05EF-4C54-9701-C4485DDEEE6B</gtr:id><gtr:name>Oxford Gene Technology</gtr:name><gtr:address><gtr:line1>Begbroke Science Park
Sandy Lane
Yarnton</gtr:line1><gtr:city>Oxford</gtr:city><gtr:postCode>OX5 1PF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A75EF746-05EF-4C54-9701-C4485DDEEE6B"><gtr:id>A75EF746-05EF-4C54-9701-C4485DDEEE6B</gtr:id><gtr:name>Oxford Gene Technology</gtr:name><gtr:address><gtr:line1>Begbroke Science Park
Sandy Lane
Yarnton</gtr:line1><gtr:city>Oxford</gtr:city><gtr:postCode>OX5 1PF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/90AE79EB-76AE-4C76-91EA-6CFFB6268480"><gtr:id>90AE79EB-76AE-4C76-91EA-6CFFB6268480</gtr:id><gtr:firstName>Tariq</gtr:firstName><gtr:surname>Enver</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137973817"><gtr:id>CF7D8F8A-488D-4094-B453-587612157318</gtr:id><gtr:title>Programming and re-programming of haemopoietic cell fate</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137973817</gtr:grantReference><gtr:abstractText>The blood is composed of a variety of different types of cells that each have specialised and distinct functions. As these cells die they are replenished by a small pool of long-lived cells known as stem cells which have the capacity both to produce more stem cells (a process termed self-renewal) or give rise to all the specialized blood cell types of the blood (a process termed differentiation). Our research programme attempts to understand, at the molecular level, how stem cells decide whether to self-renew, or to differentiate and in the latter case, into which cell type (a process termed lineage-specification). These working decisions that stem cells make are ultimately effected at the level of differential gene activity or usage, and gaining an understanding of how this process works is an important problem in developmental biology, transplantation medicine, stem cell based gene therapy and haematological malignancy. We study this process by genetically altering the activities of candidate molecular regulators of these processes. We anticipate that these studies will illuminate how normal cell fate decisions are instigated and inform approaches aimed at manipulating the expansion, directed-differentiation or reprogramming of stem cell fate for therapeutic or commercial advantage.</gtr:abstractText><gtr:technicalSummary>All the different specialised cell types that constitute the blood are derived from a multipotential haemopoietic stem cell (HSC). HSCs are long-lived and in addition to having the capacity to give rise, through differentiation, to all blood lineages, HSC are capable of extensive self-renewal. It remains unclear at the molecular level how the balance between self-renewal and differentiation is regulated and how the different blood lineages are specified. However we can presume that the process of cell type restriction involves the formation of stable transcription factor complexes that initiate and consolidate (or repress) exclusive programmes of gene expression. Transcription factors have therefore been intensively studied as candidate instigators of cell fate decisions. This capacity has been emphasised by recent studies that indicate that individual transcription factors can reprogramme the development fate of already committed cell types. In our own laboratory we have shown that the erythroid-affiliated transcription factor GATA-1 can re-specify the fate of freshly isolated, bone marrow-derived, committed neutrophil-monocyte progenitors. In response to exogenous GATA-1 activity these cells adopt erythroid or other GATA-1-affiliated cell fates. These observations provide a mechanism for reprogramming of committed haematopoietic progenitors and an experimental entry point for directly identifying the key loci involved. Since manipulation of GATA-1 activity can also alter cell fate in multipotential progenitors that express endogenous GATA-1 and retain both erythroid and neutrophil monocyte potential, the same mechanisms and loci are likely to also be directly involved in normal uni-lineage differentiation from multipotent progenitor cells. Thus our approach is to examine transcription factor-mediated alterations in cell fate primarily in the experimental context of reprogramming and apply our results to the more normal context of cell fate programming from the multipotential uncommitted state. We will ask the following questions: 1) Which cells can be reprogrammed (lineage/stage of differentiation) by a single transcription factor. 2) Which transcription factors can reprogram. 3) What is the mechanism of reprogramming, is it de-differentiation or trans-differentiation? 4) How complete is the reprogramming i.e. do the cells show residual features of their original lineage and are they fully functional? 5) To what extent is the mechanism the same regardless of the lineage/stage being reprogrammed and to what extent is it lineage/stage specific? 6) What is the detailed mechanism of reprogramming in respect of target genes, chromatin re-modelling etc. 7) Does reprogramming require cell division. 8) Can human cells be reprogrammed? 9) To what extent to the processes which mediate reprogramming also function to programme the cell fate output of multipotent cells. We anticipate that these studies will contribute to our understanding of how normal cell fate decisions are instigated and inform approaches aimed at manipulating the expansion, directed-differentiation or reprogramming of stem cell fate for therapeutic or commercial advantage.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4450541</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Network reconstruction</gtr:description><gtr:id>9AE21D94-CED9-46BC-8F15-BB4BC6CDA546</gtr:id><gtr:impact>Co-authored publication in PLOS Computational Biology PubMed ID 19165316 There has been an exchange of my MRC funded bioinformatician (Shamit Soneji) between sites. Additionally we have received bioinformatical support from other members of the theoretical physics department.</gtr:impact><gtr:outcomeId>0782B4D7A71-1</gtr:outcomeId><gtr:partnerContribution>This partnership has provided a PhD student based in the department of theoretical physics in Lund University under the direction of Carsten Petersen. This student's project is solely based on mathematical analysis of data produced by our MRC programme.</gtr:partnerContribution><gtr:piContribution>We have provided data sets and in depth knowledge of the biology of blood based stem cell systems.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Gene Technology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Micro Array Development</gtr:description><gtr:id>C206C6FA-5A69-40FE-A528-F8B9927A3C50</gtr:id><gtr:impact>Interactions with Oxford Gene Technology have lead to partnership in a new Eu framework 7 programme EuroSYSTEM. They have resulted in on going development of novel array based methods for analysis of gene expression in single cells.</gtr:impact><gtr:outcomeId>AAF22E61264-1</gtr:outcomeId><gtr:partnerContribution>OGT have provided my laboratory with state of the art micro array platforms and assisted in design of array based experiments.</gtr:partnerContribution><gtr:piContribution>We have provided consultation about stem cell biology. We have provided stem cells and cell lines and identified gene targets for technology validation.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Stem cell expansion</gtr:description><gtr:id>8FB3634D-964C-42BD-B0A5-F20146FD1B82</gtr:id><gtr:impact>We have achieved funding through the Haemato Linne Programme in Sweden to support a joint post doctoral fellow based in Sweden.</gtr:impact><gtr:outcomeId>EB680909A2C-1</gtr:outcomeId><gtr:partnerContribution>Stefan Karlsson's laboratory has assisted us with in-depth knowledge of short hair pin RNA vectors and gene therapy approaches for our studies of human blood stem cell self renewal.</gtr:partnerContribution><gtr:piContribution>We have provided candidate genes involved in self renewal and molecular biology expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Twins with Leukaemia</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DF4C9131-A468-45F0-A10C-A85129EABC83</gtr:id><gtr:impact>Prof Enver attended the Science Media Centre and presented findings recently published in Science Magazine, Hong et al 'Initiating and cancer-propagating cells in TEL-AML10 associated childhood leukaemia&amp;quot;, which pertained to the origins of childhood leukaemia.

This story was widely covered in national and international news media including the front page of The Independent and major tv coverage.</gtr:impact><gtr:outcomeId>7D00195817F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bryanstone School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5F614C7D-2791-4E60-AA3A-AF9EF604F2F8</gtr:id><gtr:impact>Prof Enver accompanied by Dr Emma Kemp from Public Outreach Division of EuroSystem (EU Framework 7) showed a movie (stem cell story) to students from the Bryanstone School Science Society - approx 70 children. Prof Enver then presented his own research in an accessible form and hosted a question and answer session on both topics. The event took approximately 2 hours.

Several school children requested laboratory placements in Prof Enver's lab and they were directed to Emma Kemp at EuroSystem for further information.</gtr:impact><gtr:outcomeId>2B0B1B17433</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ISSCR - Barcelona</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>38CEC1B0-5729-4B3E-82BD-1D72450DAD8E</gtr:id><gtr:impact>Prof Enver assembled a panel of scientists, ethisists and health care professionals to assist in a panel discussion based around short movies describing stem cells. The event was entitled &amp;quot;Everything you wanted to know about Stem cells but were afraid to ask&amp;quot; and took place at Bosmo Caixa Museum, Barcelona. It was attended by a range of scientists, patient advocate, patients, policy makers, lay public and journalists. In addition through the offices of ESTOOLS we put on a photographic exhibit entitled &amp;quot;Smile of a Stem Cell&amp;quot; which was displayed at the Cosmo Caixa Museum and open to public and scientists alike.

This is part of on-going public engagement and out reach by the ISSCR but most importantly this served as a platform for high lighting the activities of two major European networks focused on stem cell research namely EuroSystem and ESTOOLS.</gtr:impact><gtr:outcomeId>E21CDB6C1D9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Geoff Thomas</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9BD4901C-B61A-45BE-AC79-D48E9679A02A</gtr:id><gtr:impact>Prof Enver attended House of Commons to brief parliamentarians and representatives of charitable and pharmasuitacle sectors on break throughs in cancer stem cell science. This presentation was in support of the activities of the Geoff Thomas Foundation.which is raising funds for Leukaemia Research. http://www.geoffthomasfoundation.org/site/index.php?option=com_content&amp;amp;view=article&amp;amp;id=20&amp;amp;Itemid=68

Raised awareness.</gtr:impact><gtr:outcomeId>9D192D88BC5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leukaemia Research Fund Golf Charity Day, Ashridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0C8243CA-D06D-42BD-9ACF-28B30839C0FF</gtr:id><gtr:impact>Prof Enver described his research to approx 100 members of the public who had participated in a charitable golf event.

This event raised approx &amp;pound;10k for Leukaemia Research and enhanced the scientific understanding of patients and their families in respect of the diseases which afflict them.</gtr:impact><gtr:outcomeId>58DDFD2900A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lord Patel</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2B5FDAAE-0032-443E-960F-82C436D6E68F</gtr:id><gtr:impact>Prof Enver described the state of the art in stem cell biology to an assembly and parliamentarians and policymakers at the invitation of Lord Narendra Patel.

This was part of informing opinion around the issue of stem cells and there by helping to maintain progressive legislation and competitiveness in the stem cell area within the UK.</gtr:impact><gtr:outcomeId>FB415A14917</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>394168</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EuroSystem European Federation for Systematic Stem Cell Biology</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>438D98CF-83E4-4746-B2D4-43BE24A6FEB2</gtr:id><gtr:outcomeId>5E531A0430E0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>205854</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ESTOOLs - EU Framework6 integrated Project to examine mechanisms of human ES cell self renewal and differentiation</gtr:description><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>C6E68CF5-3FAB-4617-8786-DBC692449DB3</gtr:id><gtr:outcomeId>96E7CE9A3F90</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>148170</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EUROCSC - &amp;quot;STREP&amp;quot; Consortium for the study of Cancer Stem Cells</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>07706F16-270D-4CA6-92F6-2B870830C9F7</gtr:id><gtr:outcomeId>C71B266207E0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1451548</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Transcriptional programming of pre-leukaemia and leukaemia stem and progenitor cells in childhood ALL</gtr:description><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>AB0313FD-2E7A-490A-8EF8-B19391790529</gtr:id><gtr:outcomeId>Qjtzm7eP1tW0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>384233</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STEMEXPAND - Stem Cell Expansion - Expansion and engraftment of haematopoietic and mesenchymal stem cells</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F995CDA6-2184-43CF-917D-E449A62ED3A0</gtr:id><gtr:outcomeId>ABB409CE78D0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cord Blood</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1283E922-439D-4033-984D-90B99A0B7637</gtr:id><gtr:outcomeId>93E78A79FA6</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A database of gene expression profiles and transcription factor targets throughout blood lineage development.</gtr:description><gtr:id>24B34315-EFDD-4D52-AA4C-A5FCBA2C3A0A</gtr:id><gtr:impact>This database is serving to foster collaborative interactions with European colleagues including Gerald de Haan - University of Gronigen, Netherlands, Carsten Petersen, University of Lund, Sweden, Ingo Roeder University of Leipzig, Germany and Ruud Delwel Erasmus University, The Netherlands</gtr:impact><gtr:outcomeId>3EF162C8DC1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Network Database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5437510F-5F8C-4A0C-911E-DC3CB4313D2C</gtr:id><gtr:title>MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ec58a1f93ed7fd8fe7e04449a5a4afb"><gtr:id>0ec58a1f93ed7fd8fe7e04449a5a4afb</gtr:id><gtr:otherNames>Lawrie CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>2879234612E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37B246D5-6A72-4854-8913-F44B99D5B601</gtr:id><gtr:title>Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/998d180b360c2ba74d66d6719ba32b45"><gtr:id>998d180b360c2ba74d66d6719ba32b45</gtr:id><gtr:otherNames>May G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_14447_27_24120743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF5CDE2D-A26B-419C-9C28-FF36D41EA042</gtr:id><gtr:title>Computational modeling of the hematopoietic erythroid-myeloid switch reveals insights into cooperativity, priming, and irreversibility.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5728be49bb25a4d2fe86cb6a1c63aea"><gtr:id>c5728be49bb25a4d2fe86cb6a1c63aea</gtr:id><gtr:otherNames>Chickarmane V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>10A49AAF291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14600730-8710-4CFA-9A33-0CDE212BE915</gtr:id><gtr:title>GATA-2 regulates granulocyte-macrophage progenitor cell function.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b31d3907067ec7a305c091220a34ddb"><gtr:id>2b31d3907067ec7a305c091220a34ddb</gtr:id><gtr:otherNames>Rodrigues NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>CCB6744A864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C32EF5AB-0FD5-46CE-9498-70FA44D52D78</gtr:id><gtr:title>Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2ef3e0116bf828c6d85dd14f7610564"><gtr:id>b2ef3e0116bf828c6d85dd14f7610564</gtr:id><gtr:otherNames>Robert-Moreno A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>A2DF969CC49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE639D70-74EB-401D-9147-96E9ABA8FA49</gtr:id><gtr:title>Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b160b7da3fb43d8dc5b4fbbfe805f7e1"><gtr:id>b160b7da3fb43d8dc5b4fbbfe805f7e1</gtr:id><gtr:otherNames>M?nsson R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>357223806CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F76D2FED-C0A8-418A-8C5E-6E67855AA651</gtr:id><gtr:title>CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87298eb25e04df0efe4e16f397cbf682"><gtr:id>87298eb25e04df0efe4e16f397cbf682</gtr:id><gtr:otherNames>Chan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>E7FF65BBC80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F74D1B-7749-4FE5-A661-66B719A001F4</gtr:id><gtr:title>Stem cell researchers find their niche.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/021b0c585bc8af00d38dc95109a583f5"><gtr:id>021b0c585bc8af00d38dc95109a583f5</gtr:id><gtr:otherNames>Dzierzak E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>36960A4319A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>056DDAF4-B19F-46A8-AB1F-476FF4D43C0E</gtr:id><gtr:title>Inference, validation, and dynamic modeling of transcription networks in multipotent hematopoietic cells.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbeb2d74b2203dfd66aef609e557811a"><gtr:id>cbeb2d74b2203dfd66aef609e557811a</gtr:id><gtr:otherNames>Soneji S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>3B0A5B2AAB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>282F7B06-FA2C-43EE-B766-EC1ED34A6105</gtr:id><gtr:title>Molecular targeting of cancer stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff9ad9ad870a670fe88aee2fe4bc105"><gtr:id>fff9ad9ad870a670fe88aee2fe4bc105</gtr:id><gtr:otherNames>Gupta R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>1DCB351A66B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D53064DB-53FD-4ABA-8DF9-8F88148C81DC</gtr:id><gtr:title>Stem cell states, fates, and the rules of attraction.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5e23ae3b15b0a7aff6b72b42090ed2"><gtr:id>aa5e23ae3b15b0a7aff6b72b42090ed2</gtr:id><gtr:otherNames>Enver T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>8F474EADADF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3C81A7D-BBB7-44EF-9979-10A7605D57C7</gtr:id><gtr:title>Bifurcation dynamics in lineage-commitment in bipotent progenitor cells.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e250fd984493744859f95e3a21866806"><gtr:id>e250fd984493744859f95e3a21866806</gtr:id><gtr:otherNames>Huang S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>CFE562A5569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B427DCD4-F598-49AB-84DA-9EF4282E335A</gtr:id><gtr:title>Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e28caf6b287a4b147087092d071f87b"><gtr:id>8e28caf6b287a4b147087092d071f87b</gtr:id><gtr:otherNames>Hong D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>305F1D20677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04072398-9344-40F2-A323-057B3F8968B5</gtr:id><gtr:title>Developmental biology: Instructions writ in blood.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5e23ae3b15b0a7aff6b72b42090ed2"><gtr:id>aa5e23ae3b15b0a7aff6b72b42090ed2</gtr:id><gtr:otherNames>Enver T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>CCFDF857E5D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8CC8916-BB59-438D-8EE8-E48AEE6E176E</gtr:id><gtr:title>High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/799f9e52a33aaffc698711d3a7dffec7"><gtr:id>799f9e52a33aaffc698711d3a7dffec7</gtr:id><gtr:otherNames>Tipping AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>E9079EE44A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF6C537-F872-40EA-8C9B-9649E211021E</gtr:id><gtr:title>Anterior definitive endoderm from ESCs reveals a role for FGF signaling.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99483d8330748704a10568834cf1dd4b"><gtr:id>99483d8330748704a10568834cf1dd4b</gtr:id><gtr:otherNames>Morrison GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>FC58D292F2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0222A312-D0AB-46E4-BC2B-AF621567B27B</gtr:id><gtr:title>Tel1/ETV6 specifies blood stem cells through the agency of VEGF signaling.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e1d8721b35eff5f193ba2e686e600b7"><gtr:id>8e1d8721b35eff5f193ba2e686e600b7</gtr:id><gtr:otherNames>Ciau-Uitz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>NMgwyZxfYjv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BF22B34-3CFC-4FB3-9FEC-33FCBD16A9D0</gtr:id><gtr:title>Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a4de4f25ab06ec8486a5297e7e5328d"><gtr:id>3a4de4f25ab06ec8486a5297e7e5328d</gtr:id><gtr:otherNames>Goardon N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>P4qT8dgcMYJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED292AF5-ED74-44D4-B16A-976991836204</gtr:id><gtr:title>Stem cell programs are retained in human leukemic lymphoblasts.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4a0a4fdee23ea81e31252ff73e9aa74"><gtr:id>e4a0a4fdee23ea81e31252ff73e9aa74</gtr:id><gtr:otherNames>Fan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>546339bbeef1e7.38827148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AAF227B-4FB5-4FC9-A56D-ABA8F07DF513</gtr:id><gtr:title>Single-cell PCR profiling of gene expression in hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e82aa2fda95e6d5392514b422955d2"><gtr:id>32e82aa2fda95e6d5392514b422955d2</gtr:id><gtr:otherNames>Teles J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>546339bc2189b9.45539861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F7F0950-FABA-4827-80A8-93D0D01BDFFB</gtr:id><gtr:title>Genetic variegation of clonal architecture and propagating cells in leukaemia.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f374dcc13f3009fa41c40d7ef5f0f208"><gtr:id>f374dcc13f3009fa41c40d7ef5f0f208</gtr:id><gtr:otherNames>Anderson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>PcG3ETc5XRb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E81D61F1-817D-4DBB-ACD4-F8E2F9689A78</gtr:id><gtr:title>Forcing cells to change lineages.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba5583ebd22c6f7d4013eddab9e48034"><gtr:id>ba5583ebd22c6f7d4013eddab9e48034</gtr:id><gtr:otherNames>Graf T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>LVuFDZan8Go</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AB9E447-5BB3-4535-87DC-803D8ADE4976</gtr:id><gtr:title>NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff9ad9ad870a670fe88aee2fe4bc105"><gtr:id>fff9ad9ad870a670fe88aee2fe4bc105</gtr:id><gtr:otherNames>Gupta R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>ED3BB4F4FB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E700FD05-D0D4-4121-A3EE-C75CFB6A5101</gtr:id><gtr:title>MicroRNA expression in lymphocyte development and malignancy.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ec58a1f93ed7fd8fe7e04449a5a4afb"><gtr:id>0ec58a1f93ed7fd8fe7e04449a5a4afb</gtr:id><gtr:otherNames>Lawrie CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>5088D98735C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9D34F98-1FCD-455D-9FEE-6B54D2132EA8</gtr:id><gtr:title>Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/671e845978dfdb3c1fa61c3e24a55ecb"><gtr:id>671e845978dfdb3c1fa61c3e24a55ecb</gtr:id><gtr:otherNames>Yogev O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>546339bb6f05e0.24666861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>829A03EF-C424-4353-B998-75A67E64C923</gtr:id><gtr:title>DNA repair is limiting for haematopoietic stem cells during ageing.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70395f5a69bfb602d420ba8df5e7abaa"><gtr:id>70395f5a69bfb602d420ba8df5e7abaa</gtr:id><gtr:otherNames>Nijnik A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>C8BE86DA852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>622A1CCA-6087-4C12-88B3-89B4F32C6D52</gtr:id><gtr:title>Cellular network entropy as the energy potential in Waddington's differentiation landscape.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57bb8536e8eb05f9fa80b238ead2a784"><gtr:id>57bb8536e8eb05f9fa80b238ead2a784</gtr:id><gtr:otherNames>Banerji CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>pm_14447_27_24154593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A9981AB-AD06-4186-9D15-6CC7D98F4D23</gtr:id><gtr:title>Inferring rules of lineage commitment in haematopoiesis.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce41e44ad3a8609beec5365d2fdab87"><gtr:id>8ce41e44ad3a8609beec5365d2fdab87</gtr:id><gtr:otherNames>Pina C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_14447_27_22344032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8A09FEF-403A-458D-B1B2-79B455771421</gtr:id><gtr:title>Differential contributions of haematopoietic stem cells to foetal and adult haematopoiesis: insights from functional analysis of transcriptional regulators.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce41e44ad3a8609beec5365d2fdab87"><gtr:id>8ce41e44ad3a8609beec5365d2fdab87</gtr:id><gtr:otherNames>Pina C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>A363E16C595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E08FBA36-0C76-42D0-9407-90D7B6C6F869</gtr:id><gtr:title>Human induced pluripotent stem cells are capable of B-cell lymphopoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f711e8c3bb4f3993ea48b4196244ab6e"><gtr:id>f711e8c3bb4f3993ea48b4196244ab6e</gtr:id><gtr:otherNames>Carpenter L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>Qj3TCzqN7u3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5E07ABB-2595-4593-995D-9CD34229DD8E</gtr:id><gtr:title>Leukemia propagating cells rebuild an evolving niche in response to therapy.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2044b9c025cd6f61a6487016d07ef41d"><gtr:id>2044b9c025cd6f61a6487016d07ef41d</gtr:id><gtr:otherNames>Duan CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>546339bbc8bb83.35796680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15DB8C97-3443-40C6-8E99-35EB6BDD2D0C</gtr:id><gtr:title>MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fd75800ad0fe415702123899fdc3e3e"><gtr:id>6fd75800ad0fe415702123899fdc3e3e</gtr:id><gtr:otherNames>Nimmo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>pm_14447_27_23911199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D02E0FF2-8F38-4F66-B81B-62A628A42374</gtr:id><gtr:title>Coordinate gene regulation during hematopoiesis is related to genomic organization.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/591a32a920fdaa20aa91c26aa6ab60d1"><gtr:id>591a32a920fdaa20aa91c26aa6ab60d1</gtr:id><gtr:otherNames>Kosak ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>6FCD4C62CEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20607493-EFC7-47BB-98C8-06D570FEFD48</gtr:id><gtr:title>Connecting variability in global transcription rate to mitochondrial variability.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfc23a5c07a3f638ee4ba9baed8ba2b1"><gtr:id>bfc23a5c07a3f638ee4ba9baed8ba2b1</gtr:id><gtr:otherNames>das Neves RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>jwuMFwpdYph</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C6C325C-D8E6-4297-B488-8324C18C52D4</gtr:id><gtr:title>Generation of bivalent chromatin domains during cell fate decisions.</gtr:title><gtr:parentPublicationTitle>Epigenetics &amp; chromatin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176b59cd6681e624045d11349b7b0e8d"><gtr:id>176b59cd6681e624045d11349b7b0e8d</gtr:id><gtr:otherNames>De Gobbi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1756-8935</gtr:issn><gtr:outcomeId>KnPHHZM1Fsh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E249995-A87B-4555-BC2B-0BFE697287D1</gtr:id><gtr:title>Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27f67b574f6f061838c6ff5e1f4ec5d1"><gtr:id>27f67b574f6f061838c6ff5e1f4ec5d1</gtr:id><gtr:otherNames>Tsuzuki S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>CD560052400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B52482DB-4EC3-446D-9F65-586EED412DC5</gtr:id><gtr:title>Acute loss of Cited2 impairs Nanog expression and decreases self-renewal of mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a50e6d0799dc3fd6dbb34f263987df"><gtr:id>53a50e6d0799dc3fd6dbb34f263987df</gtr:id><gtr:otherNames>Kranc KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>546338d3a7a198.03553659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C140DCAE-4E38-4CB7-B425-55A647F9E971</gtr:id><gtr:title>DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f16cda57096eadc299543bf719362a1d"><gtr:id>f16cda57096eadc299543bf719362a1d</gtr:id><gtr:otherNames>Glasow A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>DF443A8DD34</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DDF49A6-360B-42E4-A634-7BA2FE0FC5EB</gtr:id><gtr:title>Hif-2a is not essential for cell-autonomous hematopoietic stem cell maintenance.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d63cc57eb2e261e0b6605a6af5e5682"><gtr:id>2d63cc57eb2e261e0b6605a6af5e5682</gtr:id><gtr:otherNames>Guitart AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_14447_27_23894152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C82DAB03-8A23-4772-832E-7B5F631C8036</gtr:id><gtr:title>Cited2 is an essential regulator of adult hematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a50e6d0799dc3fd6dbb34f263987df"><gtr:id>53a50e6d0799dc3fd6dbb34f263987df</gtr:id><gtr:otherNames>Kranc KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>BpDabH8SHGb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76AB74A6-D73D-4A3C-8235-EFD8FF55B3D4</gtr:id><gtr:title>Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec540d396589c835fdbd03ad39ca12"><gtr:id>6aec540d396589c835fdbd03ad39ca12</gtr:id><gtr:otherNames>Patel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>546339bb969d10.04121146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A14D1AC9-4DCB-4808-AE61-F6DC4AB17B00</gtr:id><gtr:title>Early dynamic fate changes in haemogenic endothelium characterized at the single-cell level.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2fe1df1f1c0d6bc5a40a742a0e29c6"><gtr:id>fe2fe1df1f1c0d6bc5a40a742a0e29c6</gtr:id><gtr:otherNames>Swiers G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>546339bc4deef6.55612195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCCBB9D6-0DE5-42CD-9180-3B7B1CD48DA7</gtr:id><gtr:title>Single-cell gene expression analysis reveals genetic associations masked in whole-tissue experiments.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6951a04aa0c935290484392c1117ca4"><gtr:id>e6951a04aa0c935290484392c1117ca4</gtr:id><gtr:otherNames>Wills QF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_14447_27_23873083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24DCA4BC-9E72-4489-98ED-F5235D9FC3BA</gtr:id><gtr:title>The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dd929da7777b268468e7e498d3540d4"><gtr:id>2dd929da7777b268468e7e498d3540d4</gtr:id><gtr:otherNames>Ford AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>EF5301F2865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41FD70E2-6D7C-4B85-A8F9-1D9DEF74341E</gtr:id><gtr:title>MLLT3 regulates early human erythroid and megakaryocytic cell fate.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce41e44ad3a8609beec5365d2fdab87"><gtr:id>8ce41e44ad3a8609beec5365d2fdab87</gtr:id><gtr:otherNames>Pina C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>B9B90DA211E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137973817</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>